Bone Marrow TransplantationTransplantation, AutologousBone MarrowHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationBone Marrow CellsStem CellsGraft vs Host DiseaseTransplantation ConditioningWhole-Body IrradiationCombined Modality TherapyMelphalanHematopoietic Stem CellsMultiple MyelomaBone Marrow PurgingRemission InductionCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeBone and BonesPeripheral Blood Stem Cell TransplantationBusulfanRecurrenceGraft SurvivalLymphoma, Non-HodgkinAnemia, AplasticLeukemiaEtoposideSalvage TherapyTransplantation ChimeraCarmustineHodgkin DiseaseDisease-Free SurvivalLiver TransplantationCytarabineHematopoietic Stem Cell MobilizationTissue DonorsThiotepaHematopoiesisSurvival AnalysisSurvival RateHistocompatibility TestingVincristineTime FactorsHistocompatibilityHematologic NeoplasmsRetrospective StudiesLeukemia, Myeloid, AcuteTransplantation, IsogeneicCell DifferentiationBone Marrow DiseasesAntigens, CD34Mice, Inbred C57BLMyeloablative AgonistsKidney TransplantationLeukemia, MyeloidFollow-Up StudiesGranulocyte Colony-Stimulating FactorImmunosuppressive AgentsRadiation ChimeraPrognosisPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphomaEmbryonic Stem CellsMesenchymal Stem Cell TransplantationMyelodysplastic SyndromesBone Marrow ExaminationAcute DiseaseAdult Stem CellsT-LymphocytesAmyloidosisGraft RejectionCells, CulturedHepatic Veno-Occlusive DiseaseColony-Forming Units AssayDexamethasoneDoxorubicinPodophyllotoxinLymphoma, FollicularBone RemodelingTransplantation ImmunologyLymphoma, Mantle-CellBone Marrow NeoplasmsPrednisoneMesenchymal Stromal CellsImmunosuppressionBoronic AcidsLymphocyte DepletionGraft vs Host ReactionFlow CytometryPyrazinesChimeraLeukocyte TransfusionAntineoplastic Agents, AlkylatingNeoplasm, ResidualHeart TransplantationSevere Combined ImmunodeficiencyHLA Antigens